Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine

Neuropsychopharmacology

Volumn 35, Issue 7, 2010, Pages 1415-1422

  Salvadore, Giacomo ^a   Cornwell, Brian R ^a   Sambataro, Fabio ^a   Latov, David ^a   Colon Rosario, Veronica ^a   Carver, Frederick ^a   Holroyd, Tom ^a   Diazgranados, Nancy ^a   MacHado Vieira, Rodrigo ^a   Grillon, Christian ^a   Drevets, Wayne C ^a   Zarate Jr , Carlos A ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Beta desynchronization; Biomarker; Magnetoencephalography (MEG); Major depressive disorder (MDD); N back

Indexed keywords

KETAMINE;

AMYGDALOID NUCLEUS; ARTICLE; BEHAVIORAL SCIENCE; CINGULATE GYRUS; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; HUMAN; MAGNETOENCEPHALOGRAPHY; MAJOR DEPRESSION; PRIORITY JOURNAL; TASK PERFORMANCE; TREATMENT RESPONSE; WORKING MEMORY;

ADULT; AMYGDALA; ANTIDEPRESSIVE AGENTS; BRAIN MAPPING; DEPRESSIVE DISORDER, MAJOR; GYRUS CINGULI; HUMANS; KETAMINE; MAGNETOENCEPHALOGRAPHY; MALE; MEMORY, SHORT-TERM; MIDDLE AGED; NEURAL PATHWAYS; NEUROPSYCHOLOGICAL TESTS; PREDICTIVE VALUE OF TESTS; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; STATISTICS AS TOPIC; TREATMENT OUTCOME;

EID: 77952428840     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.24     Document Type: Article

References (46)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders IV. American Psychiatric Association: Washington, DC.
2. Anand A, Li Y, Wang Y, Wu J, Gao S, Bukhari L et al (2005). Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsychopharmacology 30: 1334-1344.
3. Barch DM, Sheline YI, Csernansky JG, Snyder AZ (2003). Working memory and prefrontal cortex dysfunction: specificity to schizophrenia compared with major depression. Biol Psychiatry 53: 376-384.
4. Bassett DS, Bullmore ET, Meyer-Lindenberg A, Apud JA, Weinberger DR, Coppola R (2009). Cognitive fitness of cost-efficient brain functional networks. Proc Natl Acad Sci USA 106: 11747-11752.
5. Benedetti F, Mayberg HS, Wager TD, Stohler CS, Zubieta JK (2005). Neurobiological mechanisms of the placebo effect. J Neurosci 25: 10390-10402.
6. Brody AL, Saxena S, Silverman DH, Alborzian S, Fairbanks LA, Phelps ME et al (1999). Brain metabolic changes in major depressive disorder from pre-to post-treatment with paroxetine. Psychiatry Res 91: 127-139.
7. Callicott JH, Mattay VS, Bertolino A, Finn K, Coppola R, Frank JA et al (1999). Physiological characteristics of capacity constraints in working memory as revealed by functional MRI. Cereb Cortex 9: 20-26.
8. Chen CH, Suckling J, Ooi C, Fu CH, Williams SC, Walsh ND et al (2008). Functional coupling of the amygdala in depressed patients treated with antidepressant medication. Neuropsycho-pharmacology 33: 1909-1918.
9. Coppola R, Callicott JH, Holroyd T, Verchinski BA, Sust S, Weinberger DR (2004). MEG activation comparison to fMRI BOLD for a working memory task. Proceedings of the 14th International Conference on Biomagnetism, Boston, 2004, p 7.
10. Corbetta M, Miezin FM, Dobmeyer S, Shulman GL, Petersen SE (1991). Selective and divided attention during visual discriminations of shape, color, and speed: functional anatomy by positron emission tomography. J Neurosci 11: 2383-2402.
11. Cox RW (1996). AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput in Biomed Res 29: 162-173.
12. Critchley HD, Corfield DR, Chandler MP, Mathias CJ, Dolan RJ (2000). Cerebral correlates of autonomic cardiovascular arousal: a functional neuroimaging investigation in humans. J Physiol 523(Pt 1): 259-270.
13. Deakin JF, Lees J, McKie S, Hallak JE, Williams SR, Dursun SM (2008). Glutamate and the neural basis of the subjective effects of ketamine: a pharmaco-magnetic resonance imaging study. Arch Gen Psychiatry 65: 154-164.
14. DeRubeis RJ, Siegle GJ, Hollon SD (2008). Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci 9: 788-796.
15. Drevets WC, Price JL, Furey ML (2008). Brain structural and functional abnormalities in mood disorders: implications for neurocircuitry models of depression. Brain Struct Funct 213: 93-118.
16. Drevets WC, Raichle ME (1998). Reciprocal suppression of regional cerebral blood flow during emotional versus higher cognitive processes: implications for interactions between emotion and cognition. Cognit Emot 353-385.
17. First M, Spitzer RL, Gibbon M, Williams JBW (2002). Structured Clinical Interview for the DSM-IV-TR Axis I Disorders-Patient edition. Biometrics Research Department, New York State Psychiatric Institute: New York, NY.
18. Genovese CR, Lazar NA, Nichols T (2002). Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 15: 870-878.
19. George MS, Ketter TA, Parekh PI, Horwitz B, Herscovitch P, Post RM (1995). Brain activity during transient sadness and happiness in healthy women. Am J Psychiatry 152: 341-351.
20. Goldapple K, Segal Z, Garson C, Lau M, Bieling P, Kennedy S et al (2004). Modulation of cortical-limbic pathways in major depression treatment-specific effects of cognitive behavior therapy. Arch Gen Psychiatry 61: 34-41.
21. Gross J, Kujala J, Hamalainen M, Timmermann L, Schnitzler A, Salmelin R (2001). Dynamic imaging of coherent sources: studying neural interactions in the human brain. Proc Natl Acad Sci USA 98: 694-699.
22. Hamilton MC, Schutte NS, Malouff JM (1959). Hamilton Anxiety Scale [HAMA]. In: Hamilton MC (ed). Source Book of Adult Assessment (Applied Clinical Psychology). Plenum Press: New York, pp 154-157.
23. Harvey PO, Fossati P, Pochon JB, Levy R, Lebastard G, Lehéricy S et al (2005). Cognitive control and brain resources in major depression: an fMRI study using the n-back task. Neuroimage 26: 860-869.
24. Hillebrand A, Singh KD, Holliday IE, Furlong PL, Barnes GR (2005). A new approach to neuroimaging with magnetoence-phalography. Hum Brain Mapp 25: 199-211.
25. Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS et al (2007). Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 164: 778-788.
26. Langenecker SA, Kennedy SE, Guidotti LM, Briceno EM, Own LS, Hooven T et al (2007). Frontal and limbic activation during inhibitory control predicts treatment response in major depressive disorder. Biol Psychiatry 62: 1272-1280.
27. MacCallum RC, Zhang S, Preacher KJ, Rucker DD (2002). On the practice of dichotomization of quantitative variables. Psychol Methods 7: 19-40.
28. Mathew SJ, Manji HK, Charney DS (2008). Novel drugs and therapeutic targets for severe mood disorders. Neuropsycho-pharmacology 33: 2080-2092.
29. Matsuo K, Glahn DC, Peluso MAM, Hatch JP, Monkul ES, Naji P et al (2007). Prefrontal hyperactivation during working memory task in untreated individuals with major depressive disorder. Mol Psychiatry 12: 158-166.
30. Mayberg HS (2009). Targeted electrode-based modulation of neural circuits for depression. J Clin Invest 119: 717-725.
31. Mayberg HS, Brannan SK, Mahurin RK, Jerabek PA, Brickman JS, Tekell JL et al (1997). Cingulate function in depression: a potential predictor of treatment response. Neuroreport 8: 1057-1061.
32. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. Br J Psychiatry 134: 382-389.
33. Overall JE, Gorham DR (1962). The brief psychiatric rating scale. Psychol Rep 10: 790-812.
34. Phelps LE, Brutsche N, Moral JR, Luckenbaugh DA, Manji HK, Zarate Jr CA (2009). Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist. Biol Psychiatry 65: 181-184.
35. Price RB, Knock MK, Charney DS, Mathew SJ (2009). Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry 66: 522-526.
36. Rose EJ, Simonotto E, Ebmeier KP (2006). Limbic over-activity in depression during preserved performance on the n-back task. Neuroimage 29: 203-215.
37. Sackeim HA (2001). The definition and meaning of treatment-resistant depression. J Clin Psychiatry 62(Suppl) 16: 10-17.
38. Salvadore G, Cornwell BR, Colon-Rosario V, Coppola R, Grillon C, Zarate Jr CA et al (2009). Increased anterior cingulate cortical activity in response to fearful faces: a neurophysiological biomarker that predicts rapid antidepressant response to ketamine. Biol Psychiatry 65: 289-295.
39. Schoning S, Zwitserlood P, Engelien A, Behnken A, Kugel H, Schiffbauer H et al (2009). Working-memory fMRI reveals cingulate hyperactivation in euthymic major depression. Hum Brain Mapp 30: 2746-2756.
40. Singh KD, Barnes GR, Hillebrand A, Forde EM, Williams AL (2002). Task-related changes in cortical synchronization are spatially coincident with the hemodynamic response. Neuro-image 16: 103-114.
41. Talairach J, Tournoux P (1988). Co-planar Stereotaxic Atlas of the Human Brain. Thieme Medical: New York.
42. Trivedi MH, Rush AJ, Wisniewski SR, Nierenberg AA, Warden D, Ritz L et al (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice. Am J Psychiatry 163: 28-40.
43. Vrba J, Robinson SE (2001). Signal processing in magnetoence-phalography. Methods 25: 249-271.
44. Walsh ND, Williams SC, Brammer MJ, Bullmore ET, Kim J, Suckling J et al (2007). A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry 62: 1236-1243.
45. World Health Organization. (2008). The global Burden of Disease: A 2004 Update.
46. Zarate Jr CA, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA et al (2006). A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry 63: 856-864.